在老年人中减少与药物相关的不适当性 (MRI):系统性审查和元分析
Jeong-Ah Kim1, Daniel Terry2,3,4, Hoang Nguyen5
1School of Nursing, Paramedicine and Healthcare Sciences, Charles Stuart University, NSW.
Journal of patient safety
|August 14, 2025
概括
干预措施显著减少了57%的老年人与药物相关的不适当性 (MRI). 教育计划和决策支持系统改善了老年护理中的老年患者的药物安全性.
科学领域:
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 与药物相关的不适合性 (MRI) 是老年患者的重大风险,特别是在老年护理中.
- 解决MRI对于提高老年人患者的安全和健康结果至关重要.
研究的目的:
- 评估旨在减少老年人群MRI干预措施的有效性.
- 通过系统审查和元分析,改进老年护理机构的处方实践.
主要方法:
- 对RCT和非RCT进行系统审查和元分析 (2020年4月至2023年11月).
- 搜索的数据库:MEDLINE,EMBASE,CINAHL,PubMed,EBSCOhost. 搜索的数据库:MEDLINE,EMBASE,CINAHL,PubMed,EBSCOhost. 搜索的数据库:MEDLINE,EMBASE,CINAHL,PubMed,EBSCOhost. 搜索的数据库:MEDLINE,EMBASE,CINAHL,PubMed. 搜索的数据库:MEDLINE,EMBASE,CINAHL,PubMed. 搜索的数据库:MEDLINE,EMBASE,CINAHL,PubMed. 搜索的数据库:MEDLINE,PubMed. 搜索的数据库:MEDLINE,EMBASE,CINAHL,PubMed. 搜索的数据库:MEDLINE,PubMed.
- 包括8项与33,170名参与者的研究;使用随机效应模型分析了聚合几率比率 (OR).
主要成果:
- 干预措施包括教育计划,同行评审和计算机化决策支持系统.
- 观察到MRI显著减少,组合OR为0.43 (57%的减少).
- 教育干预措施在改善处方者行为和药物安全方面表现特别有效.
结论:
- 教育干预和决策支持系统有效地减少了老年患者不适当的药物处方.
- 需要进一步的研究来解决异质性,长期结果和改善药物安全的实施策略.
相关概念视频
Factors Affecting Drug Response: Overview
2.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.3K
Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33


